Sukumar Nagendran, President and Head of R&D: Taysha Gene Therapies TSHA Sell · Filed 25/08/22

Trade details

Type: Insider sale
Amount: $162,603.9
Shares · price: 57,054 sh · $2.85 a share
Held after: 1,165,289 sh
Stock: Taysha Gene Therapies TSHA
Person: Sukumar NagendranPresident and Head of R&D
Trade date: 25/08/21
Filed: 25/08/22
Days to filing: 1 days

Sold 4.7% of holdings

Share of holding sold: 4.7%

Taysha Gene Therapies trades, last 26 weeks

What else happened in Taysha Gene Therapies around then

Filed or reported within 30 days of the trade day · 25/07/22~25/09/20

Sukumar Nagendran's recent trades

Sukumar NagendranOfficer
Planned sale10b5-1 planTaysha Gene Therapies
Planned sale10b5-1 plan
Taysha Gene Therapies
TSHA
$1.3M
200,000 sh
$1.3M
Filed 07/10
Traded 07/10
Sukumar NagendranPresident and Head of R&D
Sell10b5-1 planTaysha Gene Therapies
Sell10b5-1 plan
Taysha Gene Therapies
TSHA
$892K
200,000 sh
$892K
Filed 04/13
Traded 04/10
Sukumar NagendranOfficer
Planned sale10b5-1 planTaysha Gene Therapies
Planned sale10b5-1 plan
Taysha Gene Therapies
TSHA
$926K
200,000 sh
$926K
Filed 04/10
Traded 04/10
Sukumar NagendranPresident and Head of R&D
SellTaysha Gene Therapies
Sell
Taysha Gene Therapies
TSHA
$423.4K
89,132 sh
$423.4K
Filed 01/27
Traded 01/23
Sukumar NagendranPresident and Head of R&D
SellTaysha Gene Therapies
Sell
Taysha Gene Therapies
TSHA
$124.1K
26,918 sh
$124.1K
Filed 01/27
Traded 01/26